Supernus has boosted its position in central ... are for Parkinson's disease, while the third (Myobloc) is a botulinum toxin product for cervical dystonia and chronic sialorrhea.
Hosted on MSN23d
Cantor Fitzgerald Downgrades Supernus Pharmaceuticals (SUPN)Supernus Pharmaceuticals Background Information ... for the acute treatment of hypomobility in advanced Parkinson's disease (PD); MYOBLOC® (rimabotulinumtoxinB) for the treatment of cervical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback